Trial Profile
A prospective study to evaluate the efficacy of Entecavir in patients with chronic hepatitis B virus infections in routine clinical practice in France.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Dec 2015
Price :
$35
*
At a glance
- Drugs Entecavir (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 14 Dec 2015 New trial record